EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Efficacy and safety of dupilumab versus omalizumab in patients with severe chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): Results from a prospective, head-to-head phase 4 trial

Sunday 15 Jun, 16:33 PM - 16:45 PM Glasgow, United Kingdom